Sarkozy, Andrea
Vijgen, Johan
De Potter, Tom
Schilling, Richard
Markides, Vias
Article History
Received: 9 December 2021
Accepted: 27 February 2022
First Online: 26 March 2022
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki with E6 of the International Conference of Harmonization Good Clinical Practices, ISO 14155–2011, and all applicable local and federal regulations, and was reviewed and approved by the ethics committees in all participating countries: Belgium (Ethisch comité UZA/UA, Ethische Toetsingscommissie van het Jessa Ziekenhuis and Ethisch comité van het OLV Ziekenhuis) and the UK (West of Scotland REC 4).
: All participants signed an informed consent form.
: Not applicable.
: Dr. Andrea Sarkozy reports personal fees from Biosense Webster, outside of the submitted work. Dr. Richard Schilling is a founder and shareholder of Rhythm AI; has received personal fees and grants from Biosense Webster, Abbott, Medtronic, Boehringer Ingelheim, and Daiichi Sankyo; has received non-financial support from Apple; and has served as a consultant for Biosense Webster, outside of the submitted work. Dr. Vias Markides has served as a consultant and has received speaker honoraria from Biosense Webster, outside of the submitted work. Dr. Johan Vijgen and Dr. Tom De Potter declare that they have no conflicts of interest.